Loussouarn Gildas, Sternberg Damien, Nicole Sophie, Marionneau Céline, Le Bouffant Francoise, Toumaniantz Gilles, Barc Julien, Malak Olfat A, Fressart Véronique, Péréon Yann, Baró Isabelle, Charpentier Flavien
Institut National de la Santé et de la Recherche Médicale, UMR 1087, l'Institut du ThoraxNantes, France; Centre National de la Recherche Scientifique, UMR 6291Nantes, France; Université de NantesNantes, France.
Institut National de la Santé et de la Recherche Médicale, U1127Paris, France; Sorbonne Universités, Université Pierre-et-Marie-Curie, UMR S1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225Paris, France; Institut du Cerveau et de la Moelle Épinière, ICMParis, France; Assistance Publique - Hôpitaux de Paris (AP-HP), Centres de Référence des Canalopathies Musculaires et des Maladies Neuro-musculaires Paris-EstParis, France; Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital de la Pitié Salpêtrière, Service de Biochimie Métabolique, Unité de Cardiogénétique et MyogénétiqueParis, France.
Front Pharmacol. 2016 Jan 14;6:314. doi: 10.3389/fphar.2015.00314. eCollection 2015.
Mutations in Nav1.4 and Nav1.5 α-subunits have been associated with muscular and cardiac channelopathies, respectively. Despite intense research on the structure and function of these channels, a lot of information is still missing to delineate the various physiological and pathophysiological processes underlying their activity at the molecular level. Nav1.4 and Nav1.5 sequences are similar, suggesting structural and functional homologies between the two orthologous channels. This also suggests that any characteristics described for one channel subunit may shed light on the properties of the counterpart channel subunit. In this review article, after a brief clinical description of the muscular and cardiac channelopathies related to Nav1.4 and Nav1.5 mutations, respectively, we compare the knowledge accumulated in different aspects of the expression and function of Nav1.4 and Nav1.5 α-subunits: the regulation of the two encoding genes (SCN4A and SCN5A), the associated/regulatory proteins and at last, the functional effect of the same missense mutations detected in Nav1.4 and Nav1.5. First, it appears that more is known on Nav1.5 expression and accessory proteins. Because of the high homologies of Nav1.5 binding sites and equivalent Nav1.4 sites, Nav1.5-related results may guide future investigations on Nav1.4. Second, the analysis of the same missense mutations in Nav1.4 and Nav1.5 revealed intriguing similarities regarding their effects on membrane excitability and alteration in channel biophysics. We believe that such comparison may bring new cues to the physiopathology of cardiac and muscular diseases.
Nav1.4和Nav1.5α亚基的突变分别与肌肉和心脏离子通道病相关。尽管对这些通道的结构和功能进行了深入研究,但在分子水平上描述其活性背后的各种生理和病理生理过程仍有许多信息缺失。Nav1.4和Nav1.5序列相似,表明这两个直系同源通道之间存在结构和功能同源性。这也表明,针对一个通道亚基描述的任何特征可能有助于揭示对应通道亚基的特性。在这篇综述文章中,在分别对与Nav1.4和Nav1.5突变相关的肌肉和心脏离子通道病进行简要临床描述之后,我们比较了在Nav1.4和Nav1.5α亚基表达和功能的不同方面积累的知识:两个编码基因(SCN4A和SCN5A)的调控、相关/调节蛋白,最后是在Nav1.4和Nav1.5中检测到的相同错义突变的功能效应。首先,似乎对Nav1.5表达和辅助蛋白的了解更多。由于Nav1.5结合位点与等效的Nav1.4位点高度同源,与Nav1.5相关的结果可能会指导未来对Nav1.4的研究。其次,对Nav1.4和Nav1.5中相同错义突变的分析揭示了它们对膜兴奋性和通道生物物理学改变的影响方面有趣的相似性。我们认为这种比较可能会为心脏和肌肉疾病的病理生理学带来新的线索。